National Center for Advancing Translational Sciences; Notice of Meeting, 66021 [2013-26310]

Download as PDF Federal Register / Vol. 78, No. 213 / Monday, November 4, 2013 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, October 01, 2013, 08:00 a.m. to October 02, 2013, 05:00 p.m., Bethesda Marriott Hotel, 5151 Pooks Hill Road, Bethesda, MD 20812, which was published in the Federal Register on August 16, 2013, 78FR50065. Due to the absence of either an FY 2014 appropriation or Continuing Resolution for the Department of Health and Human Services, the meeting is rescheduled for November 12–13, 2013. The meeting times and location remain the same. The meeting is closed to the public. Dated: October 29, 2013. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–26144 Filed 11–1–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting TKELLEY on DSK3SPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Arthritis and Musculoskeletal and Skin Diseases Special Emphasis Panel; Mentored Career Development, Institutional Research Training & Pathways to Independence Applications. Date: November 25, 2013. Time: 9:00 a.m. to 11:00 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Arthritis and Musculoskeletal and Skin Diseases, NIH, VerDate Mar<15>2010 17:07 Nov 01, 2013 Jkt 232001 6701 Democracy Boulevard, Suite 800, Bethesda, MD 20892. Contact Person: Charles H Washabaugh, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute of Arthritis, Musculoskeletal and Skin Diseases, NIH, 6701 Democracy Boulevard, Suite 800, Bethesda, MD 20892 (301) 496–9568, washabac@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Musculoskeletal and Skin Diseases Research, National Institutes of Health, HHS) Dated: October 29, 2013. Carolyn Baum, Program Analyst, Office of Federal Advisory Committee Policy. 66021 Advancing Translational Sciences, 1 Democracy Plaza, Room 992, Bethesda, MD 20892, 301–594–8064, Danilo.Tagle@nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Dated: October 30, 2013. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–26310 Filed 11–1–13; 8:45 am] BILLING CODE 4140–01–P [FR Doc. 2013–26182 Filed 11–1–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health Center for Scientific Review; Amended Notice of Meeting National Center for Advancing Translational Sciences; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Cures Acceleration Network Review Board. The meeting will be open to the public, viewing virtually by WebEx. Individuals can view and access the meeting by the link below. https:// ncatsevents.webex.com/ncatsevents/ onstage/g.php?t=a&d=661895283. 1. Go to ‘‘Event Status’’ on the left hand side of page, then click (Register) to complete required registration prior to joining this event. 2. ‘‘Join Event Now’’ on the right hand side of the page will automatically populate with your First Name, Last Name, and Email Address. Click ‘‘Join Now.’’ Event number: 661 895 283. Call-in toll-free number (US/Canada): 1–855–244–8681. Call-in toll number (US/Canada): 1– 650–479–3207. Access code: 661 895 283. Name of Committee: Cures Acceleration Network Review Board. Date: December 12, 2013. Time: 11:00 a.m. to 2:00 p.m. Agenda: The CAN Review Board will meet virtually to discuss how NCATS might optimally exercise its flexible research authority by using transactions other than grants, cooperative agreements and contracts. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Danilo A Tagle, Ph.D., Executive Secretary, National Center for PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 Notice is hereby given of a change in the meeting of the Molecular and Cellular Endocrinology Study Section, October 08, 2013, 08:00 a.m. to October 08, 2013, 06:30 p.m., Hilton Garden Inn Bethesda, 7301 Waverly Street, Bethesda, MD, 20814, which was published in the Federal Register on September 12, 2013, 78 FR 177 Pg. 56239. The meeting will be held at the Palomar Hotel, 2121 P Street NW., Washington, DC 20037. The meeting will start on December 9, 2013 at 7:00 a.m. and end December 9, 2013 at 6:30 p.m. The meeting is closed to the public. Dated: October 30, 2013. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–26309 Filed 11–1–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Cellular Mechanisms in Aging and Development Study Section, October 03, 2013, 08:00 a.m. to October 04, 2013, 06:00 p.m., Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814, which was published in the Federal Register on September 09, 2013, 78 FR 55086– 55087. E:\FR\FM\04NON1.SGM 04NON1

Agencies

[Federal Register Volume 78, Number 213 (Monday, November 4, 2013)]
[Notices]
[Page 66021]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-26310]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Cures Acceleration Network Review Board.
    The meeting will be open to the public, viewing virtually by WebEx.
    Individuals can view and access the meeting by the link below. 
https://ncatsevents.webex.com/ncatsevents/onstage/g.php?t=a&d=661895283.
    1. Go to ``Event Status'' on the left hand side of page, then click 
(Register) to complete required registration prior to joining this 
event.
    2. ``Join Event Now'' on the right hand side of the page will 
automatically populate with your First Name, Last Name, and Email 
Address. Click ``Join Now.''
    Event number: 661 895 283.
    Call-in toll-free number (US/Canada): 1-855-244-8681.
    Call-in toll number (US/Canada): 1-650-479-3207.
    Access code: 661 895 283.

    Name of Committee: Cures Acceleration Network Review Board.
    Date: December 12, 2013.
    Time: 11:00 a.m. to 2:00 p.m.
    Agenda: The CAN Review Board will meet virtually to discuss how 
NCATS might optimally exercise its flexible research authority by 
using transactions other than grants, cooperative agreements and 
contracts.
    Place: National Institutes of Health, One Democracy Plaza, 6701 
Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Danilo A Tagle, Ph.D., Executive Secretary, 
National Center for Advancing Translational Sciences, 1 Democracy 
Plaza, Room 992, Bethesda, MD 20892, 301-594-8064, 
Danilo.Tagle@nih.gov.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.

    Dated: October 30, 2013.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-26310 Filed 11-1-13; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.